Integrating CAR-T cell therapy into the management of DLBCL: what we are learning.
Massimo MartinoFilippo Antonio CanaleGaetana PortoChiara VerduciGiovanna UtanoGiorgia PolicastroJessyca GermanòCaterina AlatiLudovica SantoroLucrezia ImbalzanoMartina PiteaPublished in: Expert opinion on biological therapy (2023)
This review aims to describe the current landscape of CAR-T cells in DLBCL, outline their outcomes and toxicities, and explain the outstanding questions that remain to be addressed.